Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Serum sickness disease in a patient with alopecia areata and Meniere' disease after PRP procedure.

Owczarczyk-Saczonek A, Wygonowska E, Budkiewicz M, Placek W.

Dermatol Ther. 2018 Dec 4:e12798. doi: 10.1111/dth.12798. [Epub ahead of print]

PMID:
30511475
2.

Efficacy of eculizumab in severe ADAMTS13-deficient thrombotic thrombocytopenic purpura (TTP) refractory to standard therapies.

Vigna E, Petrungaro A, Perri A, Terzi D, Recchia AG, Mendicino F, La Russa A, Bossio S, De Stefano L, Zinno F, Bonofiglio R, Morabito F, Gentile M.

Transfus Apher Sci. 2018 Apr;57(2):247-249. doi: 10.1016/j.transci.2018.03.005. Epub 2018 Mar 15.

PMID:
29567368
3.

Further Investigations of the Effects of Anti-β2GP1 Antibodies on Collagen-Induced Platelet Aggregation.

Ho YC, Ahuja KDK, Adams MJ.

Clin Appl Thromb Hemost. 2018 Oct;24(7):1128-1133. doi: 10.1177/1076029617736384. Epub 2017 Nov 9.

PMID:
29121809
4.

Platelet-rich plasma exhibits beneficial effects for rheumatoid arthritis mice by suppressing inflammatory factors.

Tong S, Zhang C, Liu J.

Mol Med Rep. 2017 Oct;16(4):4082-4088. doi: 10.3892/mmr.2017.7091. Epub 2017 Jul 27.

PMID:
28765945
5.

Thrombotic thrombocytopenic purpura.

Joly BS, Coppo P, Veyradier A.

Blood. 2017 May 25;129(21):2836-2846. doi: 10.1182/blood-2016-10-709857. Epub 2017 Apr 17. Review.

6.

Homologous platelet-rich plasma for the treatment of knee involvement in primary Sjögren’s syndrome.

Bottegoni C, Farinelli L, Aquili A, Chiurazzi E, Gigante A.

J Biol Regul Homeost Agents. 2016 Oct-Dec;30(4 Suppl 1):63-67.

PMID:
28002901
7.

Use of Platelet-rich Plasma for Vulvovaginal Autoimmune Conditions Like Lichen Sclerosus.

Behnia-Willison F, Pour NR, Mohamadi B, Willison N, Rock M, Holten IW, O'Shea R, Miller J.

Plast Reconstr Surg Glob Open. 2016 Nov 23;4(11):e1124. eCollection 2016 Nov.

8.

Treating Alopecia Areata: Current Practices Versus New Directions.

Gupta AK, Carviel J, Abramovits W.

Am J Clin Dermatol. 2017 Feb;18(1):67-75. doi: 10.1007/s40257-016-0230-4. Review.

PMID:
27770310
9.

Relationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive Stage.

Morel A, Bijak M, Miller E, Rywaniak J, Miller S, Saluk J.

Oxid Med Cell Longev. 2015;2015:240918. doi: 10.1155/2015/240918. Epub 2015 Apr 29.

10.

Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop.

Anitua E, Muruzabal F, De la Fuente M, Merayo-Lloves J, Orive G.

Exp Eye Res. 2014 Feb;119:27-34. doi: 10.1016/j.exer.2013.12.005. Epub 2013 Dec 15.

PMID:
24345372
11.

A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata.

Trink A, Sorbellini E, Bezzola P, Rodella L, Rezzani R, Ramot Y, Rinaldi F.

Br J Dermatol. 2013 Sep;169(3):690-4. doi: 10.1111/bjd.12397.

PMID:
23607773
12.

Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2.

Pircher J, Merkle M, Wörnle M, Ribeiro A, Czermak T, Stampnik Y, Mannell H, Niemeyer M, Vielhauer V, Krötz F.

Arthritis Res Ther. 2012 Oct 18;14(5):R225. doi: 10.1186/ar4064.

13.

Pathophysiology of thrombotic thrombocytopenic purpura.

Tsai HM.

Int J Hematol. 2010 Jan;91(1):1-19. doi: 10.1007/s12185-009-0476-1. Review.

14.

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.

Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X.

Arthritis Res Ther. 2009;11(5):R156. doi: 10.1186/ar2833. Epub 2009 Oct 15.

15.

The application of platelet-rich plasma may be a novel treatment for central nervous system diseases.

Shen YX, Fan ZH, Zhao JG, Zhang P.

Med Hypotheses. 2009 Dec;73(6):1038-40. doi: 10.1016/j.mehy.2009.05.021. Epub 2009 Sep 19.

PMID:
19767153
16.
17.

Measuring soluble platelet glycoprotein VI in human plasma by ELISA.

Al-Tamimi M, Mu FT, Moroi M, Gardiner EE, Berndt MC, Andrews RK.

Platelets. 2009 May;20(3):143-9. doi: 10.1080/09537100802710286.

PMID:
19437330
18.

A polymorphism in the human serotonin 5-HT2A receptor gene may protect against systemic sclerosis by reducing platelet aggregation.

Beretta L, Cossu M, Marchini M, Cappiello F, Artoni A, Motta G, Scorza R.

Arthritis Res Ther. 2008;10(5):R103. doi: 10.1186/ar2495. Epub 2008 Sep 1.

19.

Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor.

Leong HS, Mahesh BM, Day JR, Smith JD, McCormack AD, Ghimire G, Podor TJ, Rose ML.

J Leukoc Biol. 2008 Feb;83(2):263-71. Epub 2007 Nov 1.

PMID:
17974709
20.

Platelet pro-aggregatory effects of CD40L monoclonal antibody.

Mirabet M, Barrabés JA, Quiroga A, Garcia-Dorado D.

Mol Immunol. 2008 Feb;45(4):937-44. Epub 2007 Oct 24. Erratum in: Mol Immunol. 2008 May;45(9):2721.

PMID:
17959249

Supplemental Content

Loading ...
Support Center